VEGF 165 Protein
-
- Target
- VEGF 165
- Protein Type
- Recombinant
-
Origin
- Rat
-
Source
- Escherichia coli (E. coli)
- Characteristics
- VEGF-A, glioma-derived endothelial cell mitogen, Vascular permeability factor (VPF)
- Purification
- Vascular Endothelial Growth Factor-165 purity was determined to be greater than 97% as determined by HpLC, analysis by UV-Spectroscopy at 280nm, and by reducing and non-reducing SDS-pAGE.
- Endotoxin Level
- Low endotoxin
-
-
- Application Notes
-
Application Note: Endothelial Growth Factor-165 Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Endothelial Growth Factor-165 in immunological assays.
Other Performance Data: Endotoxin Level: Measured by kinetic LAL analysis and is typically ≤ 1 EU/μg protein. Biologic Activity: The activity is determined by the dose-dependent induced proliferation of Human umbilical vein endothelial cells (HUVECs) and is typically 4.0-8.0 ng/mL.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
-
Reconstitution Volume: 2 μL (2-20 μL)
Reconstitution Buffer: Restore with deionized water (or equivalent)
- Buffer
-
Buffer: 0.01 M Sodium Phosphate, pH 7.5
Stabilizer: None
- Preservative
- Without preservative
- Storage
- RT,4 °C,-20 °C
- Expiry Date
- 6 months
-
- Target
- VEGF 165
- Alternative Name
- VEGF-165
-